Botensilimab Not Yet Recruiting Phase 2 Trials for Colorectal Cancer Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT06268015Botensilimab and Balstilimab Optimization in Colorectal Cancer